Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Designing the Next Generation of Biomaterials through Nanoengineering

Davis R., Duggal I., Peppas NA., Gaharwar AK.

Narrative Review on Face & Skin, published in Adv Mater (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Adv Mater (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40643040
PMCID
PMC12506621
DOI
10.1002/adma.202501761
Citations
10

Abstract (original English)

Recent advances in biomaterials science have applied nanoengineering to develop biomaterials with superior properties and tailored functionalities. These unique attributes are achieved due to the ability of nanoengineering to provide precise control over material interactions with living systems at the molecular scale. Here, key nanotechnologies employed to develop the next generation of biomaterials are critically evaluated. A diverse range of nanomaterials, differing in base materials, shapes, sizes, or surface properties can be integrated into various fabrication processes to develop these advanced biomaterials. Further investigation is required into properties such as surface energy, defects, porosity, and crystallinity, as these critically influence the physical, chemical, and biological characteristics of nanoengineered materials. Consequently, we explore diverse biomedical applications of nanoengineered biomaterials, including regenerative medicine, biomolecular delivery, additive manufacturing, immune engineering, cancer therapeutics, bioimaging, biosensing, antimicrobial devices, and tissue adhesives. Additionally, their current limitations are analyzed and emerging strategies for designing the next generation of nanoengineered biomaterials are highlighted.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
AnimalsHumansBiocompatible MaterialsTissue EngineeringRegenerative MedicineNanotechnologyNanostructures

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research